Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

Management

Lawrence Mayer, Ph.D.
Founder, President & Head of Research


Dr. Mayer has played a lead role in the discovery and development of a number of anti-cancer drugs. Dr. Mayer held senior management positions at the Canadian Liposome Company and QLT Inc. before joining the BC Cancer Agency where he directed the Investigational Drug Program. He is currently an adjunct professor in the department of pharmaceutical sciences at the University of British Columbia. Dr. Mayer has authored over 200 publications and has more than 35 patents either awarded or pending. Dr. Mayer received his B.Sc. degree summa cum laude from Wartburg and Ph.D. degree from the University of Minnesota.

< return

 

 

 


Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.